Search research articles
Contact Us
Filters
Showing results (131-140 of 227) with videos related to
Page
of 23
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 18, 2008
Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome
Philippe Armand, Haesook T Kim, Vincent T Ho, et al.
Transplantation and Cellular Therapy
|
November 20, 2023
Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor Allograft
Jessica S Little, Rémy Duléry, Roman M Shapiro, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 10, 2015
A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial
John Koreth, Haesook T Kim, Paulina B Lange, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 28, 2014
Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease
Caron A Jacobson, Lixian Sun, Haesook T Kim, et al.
Blood Advances
|
January 26, 2021
Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide
Benedetta Rambaldi, Haesook T Kim, Carol Reynolds, et al.
The Journal of Infectious Diseases
|
March 6, 2013
Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation
Timothy J Henrich, Zixin Hu, Jonathan Z Li, et al.
Blood Advances
|
September 4, 2020
Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemia
Haesook T Kim, Conner J Shaughnessy, Sharmila C Rai, et al.
Bone Marrow Transplantation
|
October 12, 2020
Correction: Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease
Natasha Kekre, Haesook T Kim, Julia Hofer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 13, 2008
Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning
Philippe Armand, Supriya Gannamaneni, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 25, 2013
Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies
Andrew M Brunner, Haesook T Kim, Erin Coughlin, et al.
Page
of 23
Search research articles
Search
Showing results (131-140 of 227) with videos related to
Sort By:
Page
of 23
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 18, 2008
Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome
Philippe Armand, Haesook T Kim, Vincent T Ho, et al.
Transplantation and Cellular Therapy
|
November 20, 2023
Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor Allograft
Jessica S Little, Rémy Duléry, Roman M Shapiro, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 10, 2015
A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial
John Koreth, Haesook T Kim, Paulina B Lange, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 28, 2014
Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease
Caron A Jacobson, Lixian Sun, Haesook T Kim, et al.
Blood Advances
|
January 26, 2021
Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide
Benedetta Rambaldi, Haesook T Kim, Carol Reynolds, et al.
The Journal of Infectious Diseases
|
March 6, 2013
Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation
Timothy J Henrich, Zixin Hu, Jonathan Z Li, et al.
Blood Advances
|
September 4, 2020
Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemia
Haesook T Kim, Conner J Shaughnessy, Sharmila C Rai, et al.
Bone Marrow Transplantation
|
October 12, 2020
Correction: Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease
Natasha Kekre, Haesook T Kim, Julia Hofer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 13, 2008
Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning
Philippe Armand, Supriya Gannamaneni, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 25, 2013
Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies
Andrew M Brunner, Haesook T Kim, Erin Coughlin, et al.
Page
of 23